Forum: Inflammatory Breast Cancer
01-20-2008, 10:00 AM
|
Replies: 0
Views: 2,826
research points to new agents targeting IBC
: Mol Cancer Ther. 2008 Jan;7(1):38-47.
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.
Aird KM, Ding...
|